Viewing Study NCT00151320


Ignite Creation Date: 2025-12-25 @ 4:09 AM
Ignite Modification Date: 2026-04-25 @ 2:00 AM
Study NCT ID: NCT00151320
Status: COMPLETED
Last Update Posted: 2018-06-19
First Post: 2005-09-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase I/II Trial of VELCADE + CHOP-Rituximab in Untreated DLCBL or Mantle Cell NHL
Sponsor: Weill Medical College of Cornell University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Hodgkin's Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None diffuse large B cell View
None mantle cell lymphoma View